CryoPort, Inc. CYRX
17.41
0.01
0.06%
as of 25 Sep
- Market cap
- $881.3M
- P/E
- 0.0×
Follow CYRX
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
8.10 | 7.27 | 6.13 | 0.00 |
P/S ratio |
2.76 | 2.73 | 2.26 | 4.25 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
217.18 | 523.06 | 110.62 | 700.23 | |
P/B ratio |
1.00 | 1.04 | 0.92 | 1.78 | |
Price to Tangible BV |
1.54 | 1.60 | 1.43 | 2.77 | |
EV/Sales |
1.48 | 1.46 | 1.08 | 3.13 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(17.04) | (29.90) | (391.21) | 73.10 | |
EV/FCF |
(7.26) | (9.14) | (7.51) | (27.30) | |
Quick Ratio |
14.84 | 2.03 | 1.97 | 1.96 | |
Current Ratio |
15.77 | 2.17 | 2.09 | 2.08 | |
Net Debt/EBITDA |
72.72 | 66.31 | 74.20 | 66.35 | |
Debt/Assets |
24.14% | 24.46% | 24.52% | 24.80% | |
Debt/Equity |
0.36 | 0.37 | 0.38 | 0.38 | |
Asset Turnover |
0.23 | 0.24 | 0.25 | 0.24 | |
Operating CF/Net income |
(0.24) | (0.07) | (0.30) | (0.11) | |
Capex/Depreciation |
(0.64) | (0.74) | (1.54) | (1.42) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
10.23% | 9.83% | 8.17% | 9.91% | |
Selling, General and Administrative Expense of Revenue |
60.44% | 60.01% | 57.78% | 57.20% | |
Intangible Assets out of Total Assets |
0.21 | 0.21 | 0.21 | 0.21 | |
Share Based Compensation of Revenue |
5.71% | 5.35% | 5.01% | 4.90% | |
Graham Net Nets |
0.47 | 0.44 | 0.49 | 0.25 | |
Graham Number |
15.76 | 16.52 | 16.56 | 0.00 | |
Earnings Yield |
12.34% | 13.75% | 16.30% | (5.73%) | |
Free Cash Flow Yield |
(7.40%) | (5.84%) | (6.34%) | (2.70%) | |
Revenue per Share |
0.88 | 0.91 | 0.96 | 0.97 | |
Operating CF per Share |
0.04 | 0.02 | 0.07 | 0.02 | |
Capex per Share |
(0.09) | (0.10) | (0.21) | (0.19) | |
Free Cash Flow per Share |
(0.04) | (0.08) | (0.13) | (0.17) | |
Cash per Share |
8.41 | 8.21 | 8.09 | 7.86 | |
Shareholders Equity per Share |
10.24 | 10.04 | 9.92 | 9.73 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
10.24 | 10.04 | 9.92 | 9.73 | |
Free Cash Flow |
(2.09) | (4.02) | (6.55) | (8.68) | |
Working Capital |
454.09 | 257.16 | 245.67 | 239.17 | |
Capital Expenditures |
(4.28) | (4.94) | (10.28) | (9.81) | |
Net Current Asset Value |
223.79 | 213.82 | 201.92 | 194.70 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.10 | 0.11 | 0.22 | 0.20 | |
Net Profit Margin |
(20.22%) | (30.02%) | (26.24%) | (20.94%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
39.19 | 29.33 | 33.69 | 34.93 | |
Average Payables |
19.54 | 15.59 | 14.69 | 15.50 | |
Average Inventory |
23.44 | 22.33 | 22.55 | 22.27 | |
Average Assets |
738.05 | 734.24 | 731.73 | 765.07 | |
Average Common Equity |
429.65 | 413.99 | 406.63 | 460.77 |
Columns are period end dates